Astellas Pharma and Japan university researchers say they have succeeded with preclinical work showing that induced pluripotent stem cells are capable of improving the symptoms of kidney failure.
The research, which was aimed at kidney failure resulting from diabetes or high blood pressure, used human cells transplanted into mice with kidney failure. The kidneys of the mice did not deteriorate, while a placebo given to mice led to acute failure, the research team reported.
The Astellas researchers worked with researchers at Kyoto University on the study.
- here's the story from Nikkei